메뉴 건너뛰기




Volumn 19, Issue 24, 1999, Pages 2-6

How to assess patient preference of migraine treatments

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

EID: 0032844154     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1177/0333102499019s2402     Document Type: Conference Paper
Times cited : (23)

References (3)
  • 1
    • 0029120324 scopus 로고
    • Migraine symptoms: Results of a survey of self-reported migraineurs
    • Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995;35:387-96
    • (1995) Headache , vol.35 , pp. 387-396
    • Silberstein, S.D.1
  • 2
    • 0002154112 scopus 로고    scopus 로고
    • Which properties do patients expect of new and improved drugs in the treatment of primary headache disorders?
    • Olesen J, Tfelt-Hansen P, editors. Lippincott-Raven
    • Göbel H, Petersen-Braun M, Heinze A. Which properties do patients expect of new and improved drugs in the treatment of primary headache disorders? In: Olesen J, Tfelt-Hansen P, editors. Headache treatment: trial methodology and new drugs. Lippincott-Raven, 1997:93-97
    • (1997) Headache Treatment: Trial Methodology and New Drugs , pp. 93-97
    • Göbel, H.1    Petersen-Braun, M.2    Heinze, A.3
  • 3
    • 0007504727 scopus 로고    scopus 로고
    • New triptan preparations can help the migraine patient
    • Dahlof CGH. New triptan preparations can help the migraine patient. Läkartidningen 1998;95:5175-86
    • (1998) Läkartidningen , vol.95 , pp. 5175-5186
    • Dahlof, C.G.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.